Phenotypic analysis of mice lacking the Tmprss2-encoded protease

Molecular and Cellular Biology

Volumn 26, Issue 3, 2006, Pages 965-975

  Kim, Tom S ^a   Heinlein, Cynthia ^a   Hackman, Robert C ^a   Nelson, Peter S ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; COMPLEMENTARY DNA; MESSENGER RNA; PROTEINASE; SERINE PROTEINASE; TESTOSTERONE; TRANSMEMBRANE SERINE PROTEASE 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CASTRATION; ENZYME ACTIVITY; FEMALE; FERTILITY; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTYPE; HORMONE SUBSTITUTION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TMPRSS2 GENE;

ANIMALS; EPITHELIUM; FEMALE; FERTILITY; MALE; MICE; PHENOTYPE; PROSTATE; PROTEIN TRANSPORT; RECEPTORS, PROTEINASE-ACTIVATED; REGENERATION; SEMINAL VESICLES; SEQUENCE DELETION; SERINE ENDOPEPTIDASES; TESTOSTERONE; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 31344447481     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.3.965-975.2006     Document Type: Article

References (55)

1. Afar, D. E., I. Vivanco, R. S. Hubert, J. Kuo, E. Chen, D. C. Saffran, A. B. Raitano, and A. Jakobovits. 2001. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Res. 61:1686-1692.
2. Bahou, W. F. 2003. Protease-activated receptors. Curr. Top. Dev. Biol. 54: 343-369.
3. Barrett, A. J., N. D. Rawlings, and J. F. Woessner. 1998. Handbook of proteolytic enzymes, 1st ed. Academic Press, Miami, Fla.
4. Bayer, C. A., S. R. Halsell, J. W. Fristrom, D. P. Kiehart, and L. von Kalm. 2003. Genetic interactions between the RhoA and Stubble-stubbloid loci suggest a role for a type II transmembrane serine protease in intracellular signaling during Drosophila imaginal disc morphogenesis. Genetics 165: 1417-1432.
5. Ben-Yosef, T., M. Wattenhofer, S. Riazuddin, Z. M. Ahmed, H. S. Scott, J. Kudoh, K. Shibuya, S. E. Antonarakis, B. Bonne-Tamir, U. Radhakrishna, S. Naz, Z. Ahmed, A. Pandya, W. E. Nance, E. R. Wilcox, T. B. Friedman, and R. J. Morell. 2001. Novel mutations of TMPRSS3 in four DFNB8/B10 families segregating congenital autosomal recessive deafness. J. Med. Genet. 38:396-400.
6. Bertog, M., B. Letz, W. Kong, M. Steinhoff, M. A. Higgins, A. Bielfeld-Ackermann, E. Fromter, N. W. Bunnett, and C. Korbmacher. 1999. Baso-lateral proteinase-activated receptor (PAR-2) induces chloride secretion in M-1 mouse renal cortical collecting duct cells. J. Physiol. 521(Pt. 1):3-17.
7. Chan, J. C., O. Knudson, F. Wu, J. Morser, W. P. Dole, and Q. Wu. 2005. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc. Natl. Acad. Sci. USA 102:785-790.
8. Chen, Y. H., B. T. Pentecost, J. A. McLachlan, and C. T. Teng. 1987. The androgen-dependent mouse seminal vesicle secretory protein IV: characterization and complementary deoxyribonucleic acid cloning. Mol. Endocrinol. 1:707-716.
9. Corpechot, C., E. E. Baulieu, and P. Robel. 1981. Testosterone, dihydrotestosterone and androstanediols in plasma, testes and prostates of rats during development. Acta Endocrinol. (Copenhagen). 96:127-135.
10. Cunningham, M. A., E. Rondeau, X. Chen, S. R. Coughlin, S. R. Holdsworth, and P. G. Tipping. 2000. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J. Exp. Med. 191:455-462.
11. Dhanasekaran, S. M., T. R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K. J. Pienta, M. A. Rubin, and A. M. Chinnaiyan. 2001. Delineation of prognostic biomarkers in prostate cancer. Nature 412:822-826.
12. Donaldson, S. H., A. Hirsh, D. C. Li, G. Holloway, J. Chao, R. C. Boucher, and S. E. Gabriel. 2002. Regulation of the epithelial sodium channel by serine proteases in human airways. J. Biol. Chem. 277:8338-8345.
13. English, H. F., R. J. Santen, and J. T. Isaacs. 1987. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11:229-242.
14. Ernst, T., M. Hergenhahn, M. Kenzelmann, C. D. Cohen, M. Bonrouhi, A. Weninger, R. Klaren, E. F. Grone, M. Wiesel, C. Gudemann, J. Kuster, W. Schott, G. Staehler, M. Kretzler, M. Hollstein, and H. J. Grone. 2002. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am. J. Pathol. 160:2169-2180.
15. Guipponi, M., G. Vuagniaux, M. Wattenhofer, K. Shibuya, M. Vazquez, L. Dougherty, N. Scamuffa, E. Guida, M. Okui, C. Rossier, M. Hancock, K. Buchet, A. Reymond, E. Hummler, P. L. Marzella, J. Kudoh, N. Shimizu, H. S. Scott, S. E. Antonarakis, and B. C. Rossier. 2002. The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro. Hum. Mol. Genet. 11:2829-2836.
16. Herter, S, D. E. Piper, W. Aaron, T. Gabriele, G. Cutler, P. Cao, A. S. Bhatt, Y. Choe, C. S. Craik, N. Walker, D. Meininger, T. Hoey, and R. J. Austin. 2005. Hepatocyte growth factor is a preferred in vitro substrate for human Hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem. J. 390:125-136.
17. Hooper, J. D., J. A. Clements, J. P. Quigley, and T. M. Antalis. 2001. Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J. Biol. Chem. 276:857-860.
18. Iacobuzio-Donahue, C. A., R. Ashfaq, A. Maitra, N. V. Adsay, G. L. Shen-Ong, K. Berg, M. A. Hollingsworth, J. L. Cameron, C. J. Yeo, S. E. Kern, M. Goggins, and R. H. Hruban. 2003. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res. 63:8614-8622.
19. Isaacs, J. T. 1987. Control of cell proliferation and cell death in the normal and neoplastic prostate, p. 85-94. In C. H. Rodgers, D. S. Coffey, G. Ctmha, J. T. Grayhack, F. Hinman, Jr., and R. Horton (ed.), Benign prostatic hyperplasia, vol. II. National Institutes of Health, Bethesda, Md.
20. Jacquinet, E, N. V. Rao, G. V. Rao, and J. R. Hoidal. 2000. Cloning, genomic organization, chromosomal assignment and expression of a novel mosaic serine proteinase: epitheliasin. FEBS Lett. 468:93-100.
21. Jacquinet, E., N. V. Rao, G. V. Rao, W. Zhengming, K. H. Albertine, and J. R. Hoidal. 2001. Cloning and characterization of the cDNA and gene for human epitheliasin. Eur. J. Biochem. 268:2687-2699.
22. Kang, J. Y., M. Dolled-Filhart, I. T. Ocal, B. Singh, C. Y. Lin, R. B. Dickson, D. L. Rinim, and R. L. Camp. 2003. Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res. 63:1101-1105.
23. Kasper, S., P. C. Sheppard, Y. Yan, N. Pettigrew, A. D. Borowsky, G. S. Prins, J. G. Dodd, M. L. Duckworth, and R. J. Matusik. 1998. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab. Investig. 78: 319-333.
24. Kirchhofer, D., M. Peek, M. T. Lipari, K. Billed, B. Fan, and P. Moran. 2005. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. FEBS Lett. 579:1945-1950.
25. Klezovitch, O., J. Chevillet, J. Mirosevich, R. L. Roberts, R. J. Matusik, and V. Vasioukhin. 2004. Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6:185-195.
26. Lee, S. L., R. B. Dickson, and C. Y. Lin. 2000. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 275:36720-36725.
27. Lin, B., C. Ferguson, J. T. White, S. Wang, R. Vessella, L. D. True, L. Hood, and P. S. Nelson. 1999. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res. 59: 4180-4184.
28. List, K., C. C. Haudenschild, R. Szabo, W. Chen, S. M. Wahl, W. Swaim, L. H. Engelholm, N. Behrendt, and T. H. Bugge. 2002. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21:3765-3779.
29. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
30. Lubieniecka, J. M., M. K. Cheteri, J. L. Stanford, and E. A. Ostrander. 2004. Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study. Prostate 59:357-359.
31. Magee, J. A., T. Araki, S. Patil, T. Ehrig, L. True, P. A. Humphrey, W. J. Catalona, M. A. Watson, and J. Milbrandt. 2001. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res. 61:5692-5696.
32. Masmoudi, S., S. E. Antonarakis, T. Schwede, A. M. Ghorbel, M. Gratri, M. P. Pappasavas, M. Drira, A. Elgaied-Boulila, M. Wattenhofer, C. Rossier, H. S. Scott, H. Ayadi, and M. Guipponi. 2001. Novel missense mutations of TMPRSS3 in two consanguineous Tunisian families with non-syndromic autosomal recessive deafness. Hum. Mutat. 18:101-108.
33. Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J. C. Roder. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90:8424-8428.
34. Netzel-Arnett, S., J. D. Hooper, R. Szabo, E. L. Madison, J. P. Quigley, T. H. Bugge, and T. M. Antalis. 2003. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev. 22:237-258.
35. Paoloni-Giacobino, A., H. Chen, M. C. Peitsch, C. Rossier, and S. E. Antonarakis. 1997. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics 44:309-320.
36. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
37. Takeuchi, T., J. L. Harris, W. Huang, K. W. Van, S. R. Coughlin, and C. S. Craik. 2000. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275:26333-26342.
38. Tanimoto, H., Y. Yan, J. Clarke, S. Korourian, K. Shigemasa, T. H. Parmley, G. P. Parham, and T. J. O'Brien. 1997. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res. 57:2884-2887.
39. Tsuji, A., A. Torres-Rosado, T. Arai, M. M. Le Beau, R. S. Lemons, S. H. Chou, and K. Kurachi. 1991. Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J. Biol. Chem. 266:16948-16953.
40. Underwood, L. J., K. Shigemasa, H. Tanimoto, J. B. Beard, E. N. Schneider, Y. Wang, T. H. Parmley, and T. J. O'Brien. 2000. Ovarian tumor cells express a novel multi-domain cell surface serine protease. Biochim. Biophys. Acta 1502:337-350.
41. Utleg, A. G., E. C. Yi, T. Xie, P. Shannon, J. T. White, D. R. Goodlett, L. Hood, and B. Lin. 2003. Proteomic analysis of human prostasomes. Prostate 56:150-161.
42. Vaarala, M. H., K. Porvari, A. Kyllonen, O. Lukkarinen, and P. Vihko. 2001. The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: detection of mutated TMPRSS2 form in a case of aggressive disease. Int. J. Cancer 94:705-710.
43. Vaarala, M. H., K. S. Porvari, S. Kellokumpu, A. P. Kyllonen, and P. T. Vihko. 2001. Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues. J. Pathol. 193:134-140.
44. Vliagoftis, H., A. Schwingshackl, C. D. Milne, M. Duszyk, M. D. Hollenberg, J. L. Wallace, A. D. Befus, and R. Moqbel. 2000. Proteinase-activated recep-tor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J. Allergy Clin. Immumol. 106:537-545.
45. Vuagniaux, G., V. Vallet, N. F. Jaeger, E. Hummler, and B. C. Rossier. 2002. Synergistic activation of ENaC by three membrane-bound channel-activating serine proteases (mCAP1, mCAP2, and mCAP3) and serum- and glucocorticoid- regulated kinase (Sgk1) in Xenopus oocytes. J. Gen. Physiol. 120:191-201.
46. Wallrapp, C., S. Hahnel, F. Muller-Pillasch, B. Burghardt, T. Iwamura, M. Ruthenburger, M. M. Lerch, G. Adler, and T. M. Gress. 2000. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res. 60:2602-2606.
47. Wilson, S., B. Greer, J. Hooper, A. Zijlstra, J. Quigley, and S. Hawthorne. 2005. The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. Biochem. J. 388:967-972.
48. Wilson, S. R., S. Gallagher, K. Warpeha, and S. J. Hawthorne. 2004. Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors. Prostate 60:168-174.
49. Wu, Q. 2001. Gene targeting in hemostasis. Hepsin. Front Biosci. 6:D192-D200.
50. Wu, Q., D. Yu, J. Post, M. Halks-Miller, J. E. Sadler, and J. Morser. 1998. Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. J. Clin. Investig. 101:321-326.
51. Van, W., N. Sheng, M. Seto, J. Morser, and Q. Wu. 1999. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J. Biol. Chem. 274:14926-14935.
52. Yan, W., F. Wu, J. Morser, and Q. Wu. 2000. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc. Natl. Acad. Sci. USA 97:8525-8529.
53. Yu, I. S., H. J. Chen, Y. S. Lee, P. H. Huang, S. R. Lin, T. W. Tsai, and S. W. Lin. 2000. Mice deficient in hepsin, a serine protease, exhibit normal embryogenesis and unchanged hepatocyte regeneration ability. Thromb. Haemost. 84:865-870.
54. Zacharski, L. R., D. L. Ornstein, V. A. Memoli, S. M. Rousseau, and W. Kisiel. 1998. Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thromb. Haemost. 79:876-877.
55. Zucker, S., and W. T. Chen (ed.). 2003. Cell surface proteases, vol. 54. Academic Press, San Diego, Calif.